Electronic cigarette substitution in the experimental tobacco marketplace: A review
- PMID: 29702131
- PMCID: PMC6685072
- DOI: 10.1016/j.ypmed.2018.04.026
Electronic cigarette substitution in the experimental tobacco marketplace: A review
Abstract
The evolution of science derives, in part, from the development and use of new methods and techniques. Here, we discuss one development that may have impact on the understanding of tobacco regulatory science: namely, the application of behavioral economics to the complex tobacco marketplace. The purpose of this paper is to review studies that examine conditions impacting the degree to which electronic nicotine delivery system (ENDS) products substitute for conventional cigarettes in the Experimental Tobacco Marketplace (ETM). Collectively, the following factors constitute the current experimental understanding of conditions that will affect ENDS use and substitution for conventional cigarettes: increasing the base price of conventional cigarettes, increasing taxation of conventional cigarettes, subsidizing the price of ENDS products, increasing ENDS nicotine strength, and providing narratives that illustrate the potential health benefits of ENDS consumption in lieu of conventional cigarettes. Each of these factors are likely moderated by consumer characteristics, which include prior ENDS use, ENDS use risk perception, and gender. Overall, the ETM provides a unique method to explore and identify the conditions by which various nicotine products may interact with one another that mimics the real world. In addition, the ETM permits the efficacy of a broad range of potential nicotine policies and regulations to be measured prior to governmental implementation.
Keywords: Behavioral economics; Cigarettes; Demand; Electronic cigarettes; Electronic nicotine delivery system; Experimental tobacco marketplace; Substitution.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest
W. K. Bickel is a principal of HealthSim, LLC and Notifius, LLC; a scientific advisory board member of Sober Grid, Inc. and DxRx, Inc.; and a consultant for ProPhase, LLC and Teva Branded Pharmaceutical Products R&D, Inc.
Figures
References
-
- Bickel WK, Marsch LA, Carroll ME, 2000. Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal. Psychopharmacology 153, 44–56. - PubMed
-
- Bickel WK, et al. , Hanoch Y, Rice T, Barnes A, 2017. The behavioral economics of tobacco products: innovations in laboratory methods to inform regulatory science In: Behavioral Economics and Health Behaviors: Key Concepts and Current Research.
-
- Chaloupka FJ, 1999. Macro-social influences: the effects of prices and tobacco-control policies on the demand for tobacco products. Nicotine Tob. Res 1 (Suppl. 1), S105–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
